Zosano Pharma Corp :Zosano Pharma Provides Corporate Update.Zosano Pharma Corp - Recently Implemented An Additional Workforce Reduction Impacting Approximately 40% Of Its Remaining Employees.Zosano Pharma Corp - In Order To Preserve Its Capital And Cash Resources, Zosano Has Suspended Its M207 Program.Zosano Pharma Corp - Suspended Gmp Manufacturing Operations At Its Fremont, California Facility.Zosano - Suspended Activities At Its Third-Party Contract Manufacturing Organizations Related To Qualification Of Commercial Manufacturing Equipment.Zosano Pharma Corp - Currently Evaluating Its Long-Lived Assets For Impairment.Zosano Pharma Corp - Remaining Feasibility Study With A Pharmaceutical Partner Is Expected To Conclude This Quarter.Zosano Pharma Corp - As Of April 26, 2022, Company Had Approximately $11.4 Million Of Cash And Cash Equivalents.Zosano Pharma - Continuing To Work With Sierraconstellation Partners As Independent Financial Advisor To Assist In Exploring Strategic Alternatives.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。